https://proteintyrosinekinasei....nhibitors.com/projec
Main analyses included all patients with ≥2 prescription fills for the index GLP-1, regardless of subsequent refill adherence or initiation of other ADM after list date. Weighed against liraglutide, neither E-ER nor E-IR had been associated with chance of composite major CVD events (hazard ratios [HRs] for E-ER and E-IR 1.33 [95% C.I. 0.73-2.39] and 1.30 [0.81-2.09]). No associations had been observed between occasion rates for individual CVD components. The HR for an
Like
Comment
Share
